Barrington Research reissued their buy rating on shares of Tivity Health (NASDAQ:TVTY) in a research note issued to investors on Tuesday morning. Barrington Research currently has a $50.00 price objective on the stock. Barrington Research also issued estimates for Tivity Health’s Q4 2018 earnings at $0.55 EPS, FY2018 earnings at $2.16 EPS, Q1 2019 earnings at $0.58 EPS, Q3 2019 earnings at $0.60 EPS, Q4 2019 earnings at $0.59 EPS, FY2019 earnings at $2.36 EPS and FY2020 earnings at $2.54 EPS.
“We expect an acceleration of revenue growth in Q4 driven largely by the company’s Prime business, which is expected to benefit from certain promotional activities.”,” the firm’s analyst wrote.
Several other equities analysts also recently weighed in on TVTY. Zacks Investment Research downgraded Tivity Health from a hold rating to a sell rating in a research report on Wednesday, July 18th. BidaskClub downgraded Tivity Health from a hold rating to a sell rating in a research report on Friday, July 27th. Finally, SunTrust Banks restated a buy rating and issued a $46.00 target price on shares of Tivity Health in a research report on Friday, August 3rd. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Tivity Health currently has an average rating of Buy and a consensus target price of $46.50.
Shares of NASDAQ TVTY traded down $0.95 during midday trading on Tuesday, hitting $37.98. The stock had a trading volume of 352,954 shares, compared to its average volume of 471,993. The company has a market cap of $1.55 billion, a PE ratio of 22.61, a price-to-earnings-growth ratio of 1.62 and a beta of 0.82. Tivity Health has a 1 year low of $31.22 and a 1 year high of $44.35. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.98 and a quick ratio of 0.77.
Tivity Health (NASDAQ:TVTY) last released its earnings results on Monday, November 5th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.02. The business had revenue of $151.50 million for the quarter, compared to the consensus estimate of $153.87 million. Tivity Health had a return on equity of 28.25% and a net margin of 13.29%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.46 earnings per share. On average, equities research analysts anticipate that Tivity Health will post 2.17 EPS for the current fiscal year.
In related news, CEO Donato Tramuto sold 35,000 shares of the stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $38.25, for a total value of $1,338,750.00. Following the completion of the sale, the chief executive officer now owns 334,743 shares of the company’s stock, valued at $12,803,919.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 8.42% of the stock is currently owned by company insiders.
Several large investors have recently bought and sold shares of the stock. Globeflex Capital L P increased its holdings in shares of Tivity Health by 12.4% in the second quarter. Globeflex Capital L P now owns 14,500 shares of the company’s stock valued at $510,000 after purchasing an additional 1,600 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Tivity Health by 15.6% in the third quarter. State of Alaska Department of Revenue now owns 12,954 shares of the company’s stock valued at $416,000 after purchasing an additional 1,745 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Tivity Health by 0.6% in the first quarter. Principal Financial Group Inc. now owns 289,546 shares of the company’s stock valued at $11,480,000 after purchasing an additional 1,790 shares during the last quarter. ClariVest Asset Management LLC increased its holdings in shares of Tivity Health by 47.8% in the second quarter. ClariVest Asset Management LLC now owns 5,879 shares of the company’s stock valued at $207,000 after purchasing an additional 1,902 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY increased its holdings in shares of Tivity Health by 16.8% in the second quarter. Metropolitan Life Insurance Co. NY now owns 14,231 shares of the company’s stock valued at $501,000 after purchasing an additional 2,045 shares during the last quarter.
About Tivity Health
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Featured Article: Moving Average (MA)
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.